Show Notes
In this episode, Brendan interviews Mike and Jen Holmes, patients from the LifestyleRx program.
Ask us a video question! https://ask-a-question.lifestylerx.ca More info: https://community.lifestylerx.io/c/the-path-podcast/
More from The Path from LifestyleRx
About the Episode For years, osteoarthritis was blamed on simple wear and tear, but new research points to inflammation and metabolic health as major drivers of joint pain. Dr. Maziar Badii explains how osteoarthritis is diagnosed, why weight loss and food choices can ease joint pain, and why exercise, even running, is rarely off limits. You will also hear how treatment works, from creams and pills to injections and joint replacement.
About the Episode As part of our late summer break, we're revisiting one of our favorite conversations from The Path archive. Most of us lose muscle as we age, and the tiny engines inside our cells, called mitochondria, get weaker too, which feeds insulin resistance and type 2 diabetes. In this episode, Dr. Mark Tarnopolsky explains how exercise, protein, and colorful foods help protect both, and why strength and endurance training each matter. He also shares how to check supplement claims, including a protein blend from his own company.
About the Episode You can develop serious liver scarring without ever drinking alcohol. Liver specialist Dr. Alnoor Ramji explains why fat in the liver deserves attention, how it connects to insulin resistance and type 2 diabetes, and which simple yearly blood test can flag liver damage early. You'll also learn which food and activity changes help, and why the liver has a strong ability to heal.
About the Episode Type 2 diabetes does not start when blood sugar rises. It starts years earlier, in the small cells of the pancreas that make insulin. Dr. Brendan Byrne talks with diabetes researcher Dr. Jim Johnson about whether too much insulin can come before insulin resistance, why many of these cells are tired rather than gone, and how rest, food choices, and exercise may help them recover.
About the Episode Some people diagnosed with type 2 diabetes have a slow, autoimmune form of diabetes called LADA, where the immune system attacks the cells that make insulin. Dr. Brendan Byrne and endocrinologist Dr. Tom Elliott explain how antibody testing works, what the newly approved drug teplizumab can and can't do, and why very low doses of Ozempic may help protect insulin-making cells. They also look ahead at the treatments that could arrive in the next five to ten years.